COVID-19 World Oncology Biosimilars Market Research Report (by Product Type, End-User/Application and Regions/Countries)

September 2020 | 98 pages | ID: C1111A9A360BEN
HeyReport

Abstracts

SUMMARY


This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Oncology Biosimilars , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Oncology Biosimilars market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc)
• Asia-Pacific (China, India, Japan, Southeast Asia etc)
• South America (Brazil, Argentina etc)
• Middle East & Africa (Saudi Arabia, South Africa etc)

By Type

• G-CSF
• Hematopoietic Agents
• Monoclonal Antibodies

By End-User / Application

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Company

• Celltrion Inc.
• Pfizer Inc.
• Biocon
• BIOCAD
• Apotex Inc.
• Dr. Reddy's
• Sandoz International GmbH
• Intas Pharmaceuticals Ltd.
• STADA Arzneimittel AG
• Teva Pharmaceutical Industries Ltd

Contents

PART 1 MARKET DEFINITION

1.1 Market Segment Overview
Figure Global Oncology Biosimilars Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Oncology Biosimilars Market and Growth by Type
1.3 by End-Use / Application
Table Global Oncology Biosimilars Market and Growth by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
Table Global Oncology Biosimilars Revenue (Million USD) by Vendors (2017-2019)
Table Global Oncology Biosimilars Revenue Share by Vendors (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by Vendors (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
Table Global Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Global Oncology Biosimilars Market Share by Type (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by Type (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
Table Global Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
Table Global Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Global Oncology Biosimilars Market Share by Regions (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by Regions (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
  5.2.1 North America
Figure North America Market Growth 2015-2018
  5.2.2 Europe
Figure Europe Market Growth 2017-2019
  5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
  5.2.4 South America
Figure South America Market Growth 2017-2019
  5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019

6 NORTH AMERICA MARKET

6.1 by Type
Table North America Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table North America Oncology Biosimilars Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table North America Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table North America Oncology Biosimilars Market Share by Regions (2017-2019)

7 EUROPE MARKET

7.1 by Type
Table Europe Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Europe Oncology Biosimilars Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Europe Oncology Biosimilars Market Share by Regions (2017-2019)

8 ASIA-PACIFIC MARKET

8.1 by Type
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market Share by Regions (2017-2019)

9 SOUTH AMERICA MARKET

9.1 by Type
Table South America Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table South America Oncology Biosimilars Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table South America Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by Regions (2017-2019)

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by Regions (2017-2019)

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
Figure Global Oncology Biosimilars Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Oncology Biosimilars Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market (Million USD) Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market Share Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Oncology Biosimilars Market (Million USD) Forecast by Type (2020-2025)
Table Global Oncology BiosimilarsMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Oncology Biosimilars Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Oncology Biosimilars Market Share Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS


12.NANCHANG SANYOU INDUSTRIAL CELLTRION INC.

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of Celltrion Inc.
12.2 Pfizer Inc.
12.3 Biocon
12.4 BIOCAD
12.5 Apotex Inc.
12.6 Dr. Reddy's
12.7 Sandoz International GmbH
12.8 Intas Pharmaceuticals Ltd.
12.9 STADA Arzneimittel AG
12.10 Teva Pharmaceutical Industries Ltd

13 OVERVIEW OF INDUSTRY DEVELOPMENT (COVID-19)

13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)

14 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Oncology Biosimilars Market and Growth by Type
Table Global Oncology Biosimilars Market and Growth by End-Use / Application
Table Global Oncology Biosimilars Revenue (Million USD) by Vendors (2017-2019)
Table Global Oncology Biosimilars Revenue Share by Vendors (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by Vendors (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Global Oncology Biosimilars Market Share by Type (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by Type (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by Type (2017-2019)
Table Global Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Global Oncology Biosimilars Market Share by Regions (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by Regions (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by Regions (2017-2019)
Table North America Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table North America Oncology Biosimilars Market Share by Type (2017-2019)
Table North America Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table North America Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table North America Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table North America Oncology Biosimilars Market Share by Regions (2017-2019)
Table Europe Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Europe Oncology Biosimilars Market Share by Type (2017-2019)
Table Europe Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table Europe Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Europe Oncology Biosimilars Market Share by Regions (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market Share by Type (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market Share by Regions (2017-2019)
Table South America Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table South America Oncology Biosimilars Market Share by Type (2017-2019)
Table South America Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table South America Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table South America Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by Regions (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by Type (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by Regions (2017-2019)
Table Global Oncology Biosimilars Market (Million USD) Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market Share Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market Volume Share Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market (Million USD) Forecast by Type (2020-2025)
Table Global Oncology BiosimilarsMarket Share by Forecast Type (2020-2025)
Table Global Oncology Biosimilars Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Oncology Biosimilars Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Celltrion Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Biocon
Table Sales Revenue, Volume, Price, Cost and Margin of BIOCAD
Table Sales Revenue, Volume, Price, Cost and Margin of Apotex Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Dr. Reddy's
Table Sales Revenue, Volume, Price, Cost and Margin of Sandoz International GmbH
Table Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of STADA Arzneimittel AG
Table Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries Ltd

List Of Figures

LIST OF FIGURES

Figure Global Oncology Biosimilars Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Oncology Biosimilars Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Oncology Biosimilars Market Volume (Volume) and Growth Forecast (2020-2025)